American Portfolios Advisors’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.2K Hold
250
﹤0.01% 3240
2022
Q2
$1.14K Hold
250
﹤0.01% 3248
2022
Q1
$1.34K Hold
250
﹤0.01% 3306
2021
Q4
$1.51K Sell
250
-600
-71% -$3.69K ﹤0.01% 3241
2021
Q3
$6.02K Hold
850
﹤0.01% 2775
2021
Q2
$7.12K Hold
850
﹤0.01% 2666
2021
Q1
$7.04K Buy
850
+600
+240% +$4.25K ﹤0.01% 2545
2020
Q4
$1.62K Hold
250
﹤0.01% 2747
2020
Q3
$1.48K Hold
250
﹤0.01% 2692
2020
Q2
$1.75K Hold
250
﹤0.01% 2587
2020
Q1
$1.3K Hold
250
﹤0.01% 2505
2019
Q4
$1.85K Hold
250
﹤0.01% 2591
2019
Q3
$2.17K Hold
250
﹤0.01% 2496
2019
Q2
$1.99K Hold
250
﹤0.01% 2484
2019
Q1
$2.57K Hold
250
﹤0.01% 2308
2018
Q4
$1.69K Buy
+250
New +$1.82K ﹤0.01% 2175

Other funds holding ULBI

American Portfolios Advisors's ULBI Position: Q3 2022 in Review

American Portfolios Advisors held its Ultralife (ULBI) position steady in Q3 2022 at 250 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

American Portfolios Advisors first reported a position in ULBI in Q4 2018 and has held it in 16 quarters since. The position peaked at $7.12K in Q2 2021. 30 funds tracked by Wall St. Rank hold ULBI as of Q3 2022.

  • American Portfolios Advisors held 250 shares of Ultralife worth $1.2K as of Q3 2022.
  • American Portfolios Advisors left its Ultralife share count unchanged in Q3 2022.
  • Ultralife made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3240 holding.
  • American Portfolios Advisors first reported a position in Ultralife in Q4 2018 and has held it in 16 quarters since.
  • American Portfolios Advisors's Ultralife position peaked at $7.12K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Ultralife as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.